Graphico

Graphico EBITDA Growth YoY

Delisted

The Year-over-Year EBITDA Growth of Graphico (4930.T) as of Nov 14, 2026 is 21.97 %. In the previous year, Year-over-Year EBITDA Growth was -27.19 % — a change of -180.81% (higher).

EBITDA Growth YoY

21.97 %

YoY

-180.81%

Last updated:

Year-over-Year EBITDA Growth of Graphico is 2023 21.97 % . Year-over-Year EBITDA Growth of Graphico was 2022 -27.19 % . It decreases by -180.81% higher compared to the previous year.

The Graphico EBITDA Growth YoY history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Growth YoY
Date
EBITDA Growth YoY
Jan 1, 2015
46.36 JPY
Jan 1, 2018
-1.93 JPY
Jan 1, 2019
19.47 JPY
Jan 1, 2020
10.66 JPY
Jan 1, 2021
35.03 JPY
Jan 1, 2022
-27.19 JPY
Jan 1, 2023
21.97 JPY
The Graphico EBITDA Growth YoY history
YEAREBITDA Growth YoYYoY
21.97 %-180.81%
-27.19 %-177.61%
35.03 %+228.66%
10.66 %-45.27%
19.47 %-1,107.62%
-1.93 %-104.17%
46.36 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Graphico Stock analysis

What does Graphico do? Graphico Inc. generates revenue through the sale of health foods, cosmetics, ethical drugs, over-the-counter drugs, and household products via drug stores, general merchandise stores, home centers, variety stores, and mail-order channels. The company outsources manufacturing and logistics while focusing on product planning, development, marketing, and sales. Its main product categories include healthcare centered on health foods, beauty care centered on cosmetics, and ethical and over-the-counter drugs. Overseas sales are handled through country-specific distributors. The company targets consumers seeking health and beauty solutions through established retail channels and direct mail-order services. Product planning and development are central to its strategy, with a focus on health foods, cosmetics, and pharmaceuticals. The firm operates as a fabless business model, relying on external partners for manufacturing and logistics to maintain agility in product innovation. Graphico Inc. serves multiple segments including health-conscious women, beauty care consumers, and individuals seeking over-the-counter medications. Sales channels include drug stores, GMS, home centers, variety stores, and mail-order systems. The company's overseas presence is supported by distributors in each country, enabling global market access without direct operational infrastructure. Graphico is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Graphico stock

Year-over-Year EBITDA Growth of Graphico is 21.97 % in 2023.

On Eulerpool you can find the complete historical development of Year-over-Year EBITDA Growth Graphico since 2006 – with annual values, charts, and detailed analysis.

EBITDA growth measures the percentage change in EBITDA compared to the prior year. It shows changes in operating cash earnings before capital structure effects.

To evaluate Year-over-Year EBITDA Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBITDA Growth.

Year-over-Year EBITDA Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBITDA Growth's Graphico historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Graphico

All Key Metrics — Graphico